Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
about
Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort.Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.Immune Checkpoint Blockade in Breast Cancer Therapy.NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67.PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments.Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record dReduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer
P2860
Q37705966-A49D96BF-90D0-41C9-AA3C-5A2414EF8FCFQ38961110-A7F6986F-DE60-4924-B489-C41ABB02DB82Q47571709-23522BDD-D97F-4F7C-BCDE-E050CB70D87BQ47844719-4134321A-E08C-4A1D-B330-FAD08459ACF0Q48234912-3427CB62-D7F5-4659-88A2-AB9A3B40EBACQ48556375-3DC5988E-BF4D-4B6C-BD73-85A8BFBF8826Q52664398-80A8C3E8-0739-47B1-A824-EF83797779C8Q52714651-1435E140-0B07-456B-B339-19C137B16863Q54935837-551C4F37-0187-40C3-8AE8-9748CDB2F741Q55027355-90F9BD6B-62DD-4163-A8F0-AE28BE264D3EQ58704497-9CF9352B-4645-4946-AC9C-EA42B4C0FD03
P2860
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@ast
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@en
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@nl
type
label
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@ast
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@en
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@nl
prefLabel
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@ast
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@en
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@nl
P2860
P356
P1476
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
@en
P2093
Christina Wu
Manojkumar Bupathi
P2860
P304
P356
10.21037/JGO.2016.07.03
P407
P577
2016-10-01T00:00:00Z